CA2885665A1 - Method for the ex vivo expansion of hematopoietic stem and progenitor cells - Google Patents

Method for the ex vivo expansion of hematopoietic stem and progenitor cells Download PDF

Info

Publication number
CA2885665A1
CA2885665A1 CA2885665A CA2885665A CA2885665A1 CA 2885665 A1 CA2885665 A1 CA 2885665A1 CA 2885665 A CA2885665 A CA 2885665A CA 2885665 A CA2885665 A CA 2885665A CA 2885665 A1 CA2885665 A1 CA 2885665A1
Authority
CA
Canada
Prior art keywords
cells
hpc
hsc
ficolin
culture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA2885665A
Other languages
English (en)
French (fr)
Inventor
Melinda L. Tursky
Mark A. Kirkland
Original Assignee
Nohla Therapeutics Australia Pty Ltd
Cytomatrix Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2011903899A external-priority patent/AU2011903899A0/en
Application filed by Nohla Therapeutics Australia Pty Ltd, Cytomatrix Pty Ltd filed Critical Nohla Therapeutics Australia Pty Ltd
Publication of CA2885665A1 publication Critical patent/CA2885665A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/145—Thrombopoietin [TPO]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/22—Colony stimulating factors (G-CSF, GM-CSF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/2306—Interleukin-6 (IL-6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/26—Flt-3 ligand (CD135L, flk-2 ligand)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/59—Lectins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA2885665A 2011-09-22 2012-09-21 Method for the ex vivo expansion of hematopoietic stem and progenitor cells Pending CA2885665A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2011903899 2011-09-22
AU2011903899A AU2011903899A0 (en) 2011-09-22 Cell culture & expansion
PCT/AU2012/001135 WO2013040644A1 (en) 2011-09-22 2012-09-21 Method for the ex vivo expansion of hematopoietic stem and progenitor cells

Publications (1)

Publication Number Publication Date
CA2885665A1 true CA2885665A1 (en) 2013-03-28

Family

ID=47913674

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2885665A Pending CA2885665A1 (en) 2011-09-22 2012-09-21 Method for the ex vivo expansion of hematopoietic stem and progenitor cells

Country Status (10)

Country Link
US (1) US9518250B2 (https=)
EP (1) EP2748309A4 (https=)
JP (1) JP6112462B2 (https=)
KR (1) KR20140063861A (https=)
CN (1) CN104114694A (https=)
AU (1) AU2012313347A1 (https=)
CA (1) CA2885665A1 (https=)
IL (1) IL231668A0 (https=)
SG (1) SG11201400851PA (https=)
WO (1) WO2013040644A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016178914A1 (en) * 2015-05-01 2016-11-10 Cesca Therapeutics, Inc. Intramuscular adaminstration of autologous bone marrw for treatment
US10669528B2 (en) * 2015-06-25 2020-06-02 Children's Medical Center Corporation Methods and compositions relating to hematopoietic stem cell expansion, enrichment, and maintenance
US20180230433A1 (en) * 2015-08-05 2018-08-16 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Use of dermatopontin for maintaining hematopoietic stem and/or progenitor cells in culture
WO2018191440A1 (en) * 2017-04-11 2018-10-18 President And Fellows Of Harvard College In vivo gene editing of blood progenitors
CN110093313B (zh) * 2018-01-29 2023-04-14 华南生物医药研究院 促进造血干/祖细胞分化为红系细胞的诱导培养基及应用
US12486519B2 (en) 2018-08-18 2025-12-02 President And Fellows Of Harvard College In situ gene editing
WO2021247749A1 (en) * 2020-06-02 2021-12-09 Cornell University Methods for expanding hematopoietic stem cells
CN115861151B (zh) * 2021-09-23 2025-10-17 鸿海精密工业股份有限公司 细胞采收提醒方法及系统

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020132017A1 (en) * 1996-12-09 2002-09-19 Moore Jeffrey G. Composition and method for preserving progenitor cells
US20050137126A1 (en) * 2003-04-09 2005-06-23 Natlmmune A/S Treatment of SARS in individuals
US20060205071A1 (en) * 2003-07-17 2006-09-14 Gamida-Cell Ltd. Methods for ex-vivo expanding stem/progenitor cells
IL161903A0 (en) * 2003-07-17 2005-11-20 Gamida Cell Ltd Ex vivo progenitor and stem cell expansion for usein the treatment of disease of endodermally- deri ved organs
CN1297659C (zh) * 2004-02-11 2007-01-31 上海伯瑞生物技术发展有限公司 一种造血细胞灌注培养方法和装置
WO2006045064A2 (en) 2004-10-20 2006-04-27 Whitehead Institute For Biomedical Research Cultured hematopoietic stem cells and method for expansion and analysis thereof
WO2007066352A1 (en) * 2005-12-06 2007-06-14 Department Of Biotechnology A method for preservation of human hematopoietic stem or progenitor cells
JP2008237136A (ja) * 2007-03-28 2008-10-09 Foundation For Biomedical Research & Innovation ヒト造血細胞の培養方法
WO2008149129A1 (en) * 2007-06-08 2008-12-11 Nova Thera Limited Cell expansion
CN101508975A (zh) * 2009-03-26 2009-08-19 大连理工大学 一种低氧条件下微囊化成骨细胞支持和调控造血干/祖细胞体外扩增的方法
EP2440930B1 (en) * 2009-06-10 2014-08-13 Rigshospitalet Ficolin-3 assay
WO2011030581A1 (ja) 2009-09-09 2011-03-17 シャープ株式会社 ジェスチャー判定装置およびその方法
US9062287B2 (en) 2009-09-11 2015-06-23 Takara Bio Inc. Process for production of natural killer cells

Also Published As

Publication number Publication date
AU2012313347A1 (en) 2014-05-08
EP2748309A4 (en) 2015-03-11
US20140286915A1 (en) 2014-09-25
WO2013040644A1 (en) 2013-03-28
IL231668A0 (en) 2014-05-28
KR20140063861A (ko) 2014-05-27
CN104114694A (zh) 2014-10-22
JP2014527820A (ja) 2014-10-23
JP6112462B2 (ja) 2017-04-12
EP2748309A1 (en) 2014-07-02
SG11201400851PA (en) 2014-04-28
US9518250B2 (en) 2016-12-13

Similar Documents

Publication Publication Date Title
US9518250B2 (en) Method for the ex vivo expansion of hematopoietic stem and progenitor cells
Ehring et al. Expansion of HPCs from cord blood in a novel 3D matrix
Lo Iacono et al. Wharton’s jelly mesenchymal stromal cells as a feeder layer for the ex vivo expansion of hematopoietic stem and progenitor cells: a review
GB2455472A (en) Structure enclosing hematopoietic progenitor cells from ES cells and method for preparing blood cells using the same
JP7713233B2 (ja) ヒト造血幹細胞を培養するために適したアルブミンフリーの無血清培地およびアルブミンフリーの培養方法
WO2021173458A1 (en) Generating aorta-gonad-mesonephros-like hematopoietic cells from human pluripotent stem cells under a defined condition
US20250297222A1 (en) Xeno-free generation of tissue-specific progenitor cells
AU2016296920B2 (en) CD34+CD41dim megakaryocytes progenitors and uses thereof for producing proplatelet-bearing MKs and/or platelets
JP2009296889A (ja) 造血幹細胞の培養方法
CA2219869A1 (en) Human cd-34 hematopoietic stem cells
Kim et al. Generation of CD34+ cells from human embryonic stem cells using a clinically applicable methodology and engraftment in the fetal sheep model
Romanov et al. Human umbilical cord mesenchymal stromal cells support viability of umbilical cord blood hematopoietic stem cells but not the “stemness” of their progeny in co-culture
Kwok et al. Maternal plasma or human serum albumin in wash buffer enhances enrichment and ex vivo expansion of human umbilical cord blood CD34+ cells
Ookura et al. Adipocyte differentiation of human marrow mesenchymal stem cells reduces the supporting capacity for hematopoietic progenitors but not for severe combined immunodeficiency repopulating cells
AU2003233677A1 (en) Cytokine-free growth and maintenance of progenitor cells
Mizokami et al. Preferential expansion of human umbilical cord blood-derived CD34-positive cells on major histocompatibility complex-matched amnion-derived mesenchymal stem cells
JP2008237136A (ja) ヒト造血細胞の培養方法
KR101149007B1 (ko) 생착능이 증가된 조혈줄기세포의 제조방법
KR100702862B1 (ko) 제대혈 유래 간엽줄기세포를 세포영양막으로 이용한조혈모세포/전구세포의 체외 성장 및 증식방법
Hasan Characterizing the Impact of the RNA Demethylase ALKBH5 on Hematopoietic Stem and Progenitor Cells
Kelley et al. Collection and Expansion of Stem Cells
Li et al. Qiuyang Li1, Dewan Zhao1, Qiang Chen2, Maowen Luo2, Jingcao Huang1, Cao Yang2, Fangfang Wang1
Mohammed Improvement and Comparison of Mesenchymal Stem Cell Cultivation from Umbilical Cord Using Different Concentrations of Fetal Bovine Serum and Platelets Lysate
Kim Culture of Umbilical Cord-and Cord Blood-Derived Stem Cells
Gonçalvesa et al. A Stro-1ş human universal stromal feeder layer to expand/maintain human bone marrow hematopoietic stem/progenitor cells in a serum-free culture system

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20170817